Capital World Investors Ionis Pharmaceuticals Inc Transaction History
Capital World Investors
- $592 Billion
- Q1 2025
A detailed history of Capital World Investors transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Capital World Investors holds 12,361,994 shares of IONS stock, worth $421 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
12,361,994
Previous 11,465,413
7.82%
Holding current value
$421 Million
Previous $401 Million
6.95%
% of portfolio
0.06%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding IONS
# of Institutions
400Shares Held
146MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$558 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$550 Million0.32% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$351 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$286 Million0.05% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.85MShares$267 Million5.5% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.83B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...